$1.50
2.74%
Nasdaq, Sep 18, 04:00 pm EDT. Closed.
ISIN
US69353Y1038
Symbol
PMVP

PMV Pharmaceuticals Inc Stock price

$1.50
+0.26 20.97% 1M
+0.01 0.67% 6M
+0.25 20.00% YTD
+0.27 21.95% 1Y
-4.71 75.85% 3Y
-25.34 94.41% 5Y
-16.50 91.67% 10Y
-16.50 91.67% 20Y
Nasdaq, Closing price Fri, Sep 18 2026
+0.04 2.74%
ISIN
US69353Y1038
Symbol
PMVP
Industry

Is PMV Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.

Key metrics

Basic
Market capitalization
$113.3m
Enterprise Value
$33.8m
Net debt
positive
Cash
$79.4m
Shares outstanding
53.5m
Valuation (TTM | estimate)
P/E
negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
1.6
Financial Health
Equity Ratio
89.8%
Return on Equity
-74.2%
ROCE
-111.4%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-79.5m
EBIT
$-79.7m
Net Income
$-75.2m
Free Cash Flow
$-71.3m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
12.6%
EBIT
12.9%
Net Income
7.0%
Free Cash Flow
-1.6%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow
-
More
EPS
$-1.4
FCF per Share
$-1.3
Short interest
4.4%
Employees
54
Rev per Employee
$0.0

PMV Pharmaceuticals Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a PMV Pharmaceuticals Inc forecast:

11x Buy
92%
1x Hold
8%

Analyst Opinions

12 Analysts have issued a PMV Pharmaceuticals Inc forecast:

Buy
92%
Hold
8%

Financial data from PMV Pharmaceuticals Inc

Jun '26
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 16 16
37% 37%
-
- Research and Development Expense 64 64
4% 4%
-
-80 -80
13% 13%
-
- Depreciation and Amortization 0.12 0.12
75% 75%
-
EBIT (Operating Income) EBIT -80 -80
13% 13%
-
Net Profit -75 -75
7% 7%
-

In millions USD.

Don't miss a Thing! We will send you all news about PMV Pharmaceuticals Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PMV Pharmaceuticals Inc Stock News

Neutral
GlobeNewsWire
20 days ago
PRINCETON, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, announced today the pricing of an underwritten public offering consisting of (i) 22,055,000 shares of its common stock and, in lieu of common stock to certain i...
Neutral
GlobeNewsWire
20 days ago
PRINCETON, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, announced today that it has commenced an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of its common s...
Neutral
GlobeNewsWire
20 days ago
PRINCETON, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, today announced updated interim ovarian cancer data from the Phase 2 pivotal portion of the PYNNACLE clinical trial. The multicenter, single-arm, registrational...
More PMV Pharmaceuticals Inc News

Company Profile

PMV Pharmaceuticals, Inc. engages in the development of p53 targeted small molecule drugs for the treatment of cancer. It combines unique biological understanding with pharmaceutical development focus. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in 2013 and is headquartered in New Jersey, NY.

Head office United States
CEO Dr. Mack
Employees 54
Founded 2013
Website www.pmvpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today